Multi-peptide Vaccination
Multi-peptide Vaccination Uses, Dosage, Side Effects, Food Interaction and all others data.
Sponsored by the University Hospital Tuebingen in Germany, Multi-peptide Vaccination is a multi-peptide COVID-19 vaccine candidate created from HLA class I and HLA-DR T-cell epitopes of the S-protein. It is being investigated in the clinical trial NCT04546841 (Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults (pVAC)) and aims to induce broad T-cell immunity.
| Trade Name | Multi-peptide Vaccination |
| Generic | CoVac-1 |
| CoVac-1 Other Names | Multi-peptide vaccination, Multipeptide cocktail |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Multi-peptide Vaccination
